Page last updated: 2024-08-24

valsartan and Complications of Diabetes Mellitus

valsartan has been researched along with Complications of Diabetes Mellitus in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (45.83)	29.6817
2010's	13 (54.17)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaikwad, AB; Malek, V	1
Baffoni, C; Borretta, G; Feola, M; Gamarra, E; Tassone, F	1
Eckert, S; Freytag, SB; Klebs, SH; Müller, A	1
Aksnes, TA; Holzhauer, B; Hua, TA; Julius, S; Kjeldsen, SE; Rostrup, M	1
Brandenburg, VM; Marx, N; Rocca, HB	1
Callan, PD; Clark, AL	1
Kondo, T; Maeda, K; Matsushita, K; Muramatsu, T; Murohara, T; Shintani, S	1
Akhtari, S; Andalib, A; Curnew, G; Leclerc, JM; Rigal, R; Tardif, JC; Vaillancourt, M	1
Konta, T; Kubota, I; Miyamoto, T; Miyashita, T; Nishiyama, S; Nitobe, J; Shishido, T; Takasaki, S; Takeishi, Y; Watanabe, T	1
Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A	1
Vértes, A	1
Cao, G; Deng, Y; Ding, X; Li, H; Xu, X; Zhang, X; Zhuang, X	1
Al Balushi, KA; Al-Zakwani, I; Habib, JQ	1
Jermendy, G; Matos, L; Winkler, G	1
Cooper, ME; Thomas, MC	1
Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ	1
Ambrosi, P; Andrejak, M; Drici, MD; Herpin, D; Pithois-Merli, I	1
Ruilope, LM	1
Angeli, F; Reboldi, G; Verdecchia, P	1
Aksnes, TA; Hua, TA; Julius, S; Kjeldsen, SE; Omvik, P; Rostrup, M	1
Bai, A; Bianchi, R; Cuccovillo, I; De Angelis, N; Fiordaliso, F; Latini, R; Masson, S; Razzetti, R; Salio, M; Serra, DM	1
Anavekar, NS; Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Solomon, SD; Velazquez, E; White, H	1
Anderson, RE; Califf, RM; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Thune, JJ; Velazquez, E; White, HD	1

Reviews

10 review(s) available for valsartan and Complications of Diabetes Mellitus

Article	Year
Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications? Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 90 Topics: Aminobutyrates; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Humans; Neprilysin; Renal Insufficiency, Chronic; Tetrazoles; Valsartan	2017
Meta-analysis of three observational studies of amlodipine/valsartan in hypertensive patients with additional risk factors. Blood pressure, 2013, Volume: 22 Suppl 1 Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Obesity, Abdominal; Risk Factors; Tetrazoles; Valine; Valsartan	2013
[Sacubitril / Valsartan in patients with diabetes and heart failure]. Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:22 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Evidence-Based Medicine; Heart Failure; Humans; Tetrazoles; Treatment Outcome; Valsartan	2016
Heart failure - what's new and what's changed? Clinical medicine (London, England), 2016, Volume: 16, Issue:Suppl 6 Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Diabetes Complications; Drug Combinations; Heart Failure; Humans; Positive-Pressure Respiration; Practice Guidelines as Topic; Sleep Apnea, Central; Tetrazoles; Valsartan	2016
Combination delapril/manidipine as antihypertensive therapy in high-risk patients. Clinical drug investigation, 2011, Volume: 31, Issue:7 Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan	2011
[Cardiologic and diabetologic aspects of therapy with angiotensin receptor blocking agents]. Orvosi hetilap, 2003, Sep-21, Volume: 144, Issue:38 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Complications; Heart Failure; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2003
Blockade of the renin-angiotensin system: better late than never. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Complications; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Peritoneal Dialysis, Continuous Ambulatory; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2004
[The best of clinical pharmacology in 2004]. Archives des maladies du coeur et des vaisseaux, 2005, Volume: 98 Spec No 1 Topics: Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Diabetes Complications; Humans; Obesity; Tetrazoles; Valine; Valsartan	2005
Update on the efficacy of angiotensin receptor blockers in treatment of hypertension. The American journal of managed care, 2005, Volume: 11, Issue:13 Suppl Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Captopril; Diabetes Complications; Drug Evaluation; Humans; Hypertension; Losartan; Tetrazoles; Treatment Outcome; Valine; Valsartan	2005
New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Complications; Diabetic Neuropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan	2000

Trials

7 trial(s) available for valsartan and Complications of Diabetes Mellitus

Article	Year
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial. Blood pressure, 2016, Volume: 25, Issue:4 Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Female; Heart Failure; Hospitalization; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Risk Factors; Valsartan	2016
Rationale and design of the NAGOYA HEART Study: comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance. Journal of cardiology, 2010, Volume: 56, Issue:1 Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Complications; Humans; Hypertension; Middle Aged; Prospective Studies; Tetrazoles; Valine; Valsartan	2010
Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets). Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:2 Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; C-Reactive Protein; Diabetes Complications; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Tetrazoles; Valine; Valsartan	2011
Efficacy and safety of valsartan in reducing blood pressure and albuminuria in Chinese patients with essential hypertension: a multicenter prospective open-label observational study. Current medical research and opinion, 2012, Volume: 28, Issue:10 Topics: Aged; Albuminuria; Antihypertensive Agents; Asian People; Blood Pressure; China; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Tetrazoles; Valine; Valsartan	2012
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:3 Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Complications; Diabetic Angiopathies; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Hypertension; Incidence; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Tetrazoles; Valine; Valsartan	2007
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. The American journal of cardiology, 2008, Apr-01, Volume: 101, Issue:7 Topics: Aged; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Diabetes Complications; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left	2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American heart journal, 2008, Volume: 155, Issue:4 Topics: Adult; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Sex Factors; Smoking; Survivors; Tetrazoles; Valine; Valsartan	2008

Other Studies

7 other study(ies) available for valsartan and Complications of Diabetes Mellitus

Article	Year
Reduction of Insulin Requirement After Starting Treatment With Sacubitril/Valsartan in a Patient with Diabetes Treated With Continuous Subcutaneous Insulin Infusion (CSII): A case report. Journal of diabetes science and technology, 2018, Volume: 12, Issue:6 Topics: Aminobutyrates; Biphenyl Compounds; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Humans; Infusions, Subcutaneous; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Middle Aged; Tetrazoles; Valsartan	2018
Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Internal medicine journal, 2012, Volume: 42, Issue:3 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Comorbidity; Diabetes Complications; Drug Therapy, Combination; Dyslipidemias; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Masked Hypertension; Middle Aged; Obesity; Prevalence; Primary Health Care; Quebec; Risk; Tetrazoles; Valine; Valsartan; White Coat Hypertension	2012
[The significance of generic valsartan in the treatment of patients]. Lege artis medicinae : uj magyar orvosi hirmondo, 2011, Volume: 21, Issue:2 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drugs, Generic; Humans; Hypertension; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2011
Comparative efficacy of irbesartan/ hydrochlorothiazide and valsartan/hydrochlorothiazide combination in lowering blood pressure: a retrospective observational study in Oman. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2013, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Oman; Retrospective Studies; Tetrazoles; Valine; Valsartan	2013
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation, 2004, Sep-21, Volume: 110, Issue:12 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left	2004
New-onset diabetes, antihypertensive treatment, and outcome. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:3 Topics: Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Drug Administration Schedule; Humans; Hypertension; Prognosis; Risk Assessment; Risk Factors; Tetrazoles; Valine; Valsartan	2007
Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats. Life sciences, 2007, Sep-01, Volume: 81, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Experimental; Hypertension; Male; Metoprolol; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin; Tetrazoles; Valine; Valsartan	2007

chemdatabank.com